Design and implementation of resuscitation research: Special challenges and potential solutions

Resuscitation

Volumn 73, Issue 3, 2007, Pages 337-346

  Nichol, Graham ^a   Huszti, Ella ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Analysis; Consent; Resuscitation; Trial design

Indexed keywords

ENVIRONMENT; EXTERNAL VALIDITY; FALSE POSITIVE RESULT; HUMAN; INFORMED CONSENT; INTERNAL VALIDITY; INTERVENTION STUDY; MEDICAL PRACTICE; POPULATION; PRIORITY JOURNAL; RESEARCH; RESUSCITATION; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT RESPONSE;

DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RESUSCITATION;

EID: 34248582974     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2006.10.021     Document Type: Review

References (65)

1. Altman D.G., and Bland J.M. Absence of evidence is not evidence of absence. Br Med J 311 7003 (1995) 485
2. Sackett D.L. The competing objectives of randomized trials. N Engl J Med 303 18 (1980) 1059-1060
3. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet 354 9180 (1999) 716-722
4. Van de Werf F., Cannon C.P., Luyten A., Houbracken K., McCabe C.H., Berioli S., et al. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. Am Heart J 137 5 (1999) 786-791
5. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329 (1993) 673-682
6. Anonymous. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Circulation 90 4 (1994) 1631-1637
7. Anonymous. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N Engl J Med 335 11 (1996) 775-782
8. Anonymous. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 2 8498 (1986) 57-66
9. Anonymous. Effectiveness of intravenous thrombolytic treatment in acute myocardial, infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1 8478 (1986) 397-402
10. Anonymous. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial, infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet 336 8707 (1990) 65-71 [see comments]
11. Anonymous. In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without, heparin. The International Study Group. Lancet 336 8707 (1990) 71-75 [see comments]
12. Anonymous. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial, infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico. Lancet 343 8906 (1994) 1115-1122 [see comments]
13. Anonymous. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 2 8607 (1988) 349-360 [see comments]
14. Anonymous. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial, infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 339 8796 (1992) 753-770 [see comments]
15. Spohr F., Arntz H.R., Bluhmki E., Bode C., Carli P., Chamberlain D., et al. International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest 35 5 (2005) 315-323
16. Lubsen J., and Tijssen J.G. Large trials with simple protocols: indications and contraindications. Contr Clin Trials 10 Suppl 4 (1989) 151S-160S
17. Hallstrom A.P., Ornato J.P., Weisfeldt M., Travers A., Christenson J., McBurnie M.A., et al. Public-access defibrillation and survival after out-of-hospital cardiac arrest. N Engl J Med 351 7 (2004) 637-646
18. Stiell I.G., Wells G.A., Spaite D.W., Lyver M.B., Munkley D.P., Field B.J., et al. The Ontario Prehospital Advanced Life Support (OPALS) Study: rationale and methodology for cardiac arrest patients. Ann Emerg Med 32 2 (1998) 180-190
19. Stiell I.G., Wells G.A., Spaite D.W., Nichol G., O'Brien B., Munkley D.P., et al. The Ontario Prehospital Advanced Life Support (OPALS) study. Part II. Rationale and methodology for trauma and respiratory distress patients. OPALS Study Group. Ann Emerg Med 34 2 (1999) 256-262
20. Cook T.D., and Campbell D.T. Quasi-experimentation: design and analysis issues for field settings (1979), Rand McNally Inc., Chicago, IL
21. Cobb L.A., Fahrenbruch C.E., Olsufka M., and Copass M.K. Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA 288 23 (2002) 3008-3013
22. Herlitz J., Eek M., Holmberg M., and Holmberg S.D. Weekly and seasonal rhythm of out of hospital cardiac arrest in Sweden. Resuscitation 54 2 (2002) 133-138
23. Anonymous. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. The Hypothermia after Cardiac Arrest Study Group. N Engl J Med 346 8 (2002) 549-556 [Erratum appears in N Engl J Med 30 May 2002;346(22):1756]
24. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 8 (2002) 557-563 [comment]
25. Abella B.S., Rhee J.W., Huang K.N., Vanden Hoek T.L., and Becker L.B. Induced hypothermia is underused after resuscitation from cardiac arrest: a current practice survey. Resuscitation 64 2 (2005) 181-186
26. Friedman L.M., Furberg C.D., and Demets D.L. Fundamentals of clinical trials. 2nd ed. (1985)
27. Rosenberger W.F., and Lachin J.M. Randomization in clinical trials, theory and practice (2002), John Wiley and Sons, New York
28. Krischer J.P., Fine E.G., Weisfeldt M.L., Guerci A.D., Nagel E., and Chandra N. Comparison of prehospital conventional and simultaneous compression-ventilation cardiopulmonary resuscitation. Crit Care Med 17 12 (1989) 1263-1269
29. Kudenchuk P.J., Cobb L.A., Copass M.K., Cummins R.O., Doherty A.M., Fahrenbruch C.E., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341 12 (1999) 871-878
30. Donner A., and Klar N. Design and analysis of cluster randomisation trials in health research (2000), Arnold, New York
31. Hsieh F.Y., Lavori P.W., Cohen H.J., and Feussner J.R. An overview of variance inflation factors for sample-size calculation. Eval Health Prof 26 3 (2003) 239-257
32. Brown H. Applied mixed models in medicine (2000), John Wiley and Sons, New York
33. Longstreth Jr. W.T., Fahrenbruch C.E., Olsufka M., Walsh T.R., Copass M.K., and Cobb L.A. Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest. Neurology 59 4 (2002) 506-514 [comment]
34. Byar D.P., Herzberg A.M., and Tan W.Y. Incomplete factorial designs for randomized clinical trials. Statist Med 12 17 (1993) 1629-1641
35. Brittain E., and Wittes J. Factorial designs in clinical trials: the effects of non-compliance and subadditivity. Statist Med 8 2 (1989) 161-171
36. US Department of Health and Human Services. Protection of Human Subjects. 45 CFR 46116; 1997. p. 115.
37. Food and Drug Administration of the United States. Protection of Human Subjects. 21 CFR 5023 (1979); 1998. p. 246-7.
38. Nichol G., Huszti E., Rokosh J., Dumbrell A., McGowan J., and Becker L. Impact of informed consent requirements on cardiac arrest research in the United States: exception from consent or from research?. Resuscitation 62 1 (2004) 3-23
39. Liddell K., Chamberlain D., Menon D.K., Bion J., Kompanje E.J., Lemaire F., et al. The European Clinical Trials Directive revisited: the VISEAR recommendations. Resuscitation 69 1 (2006) 9-14
40. Nichol G., Powell J.L., Van Ottingham L., Maier R., Rea T.D., Christenson J., et al. Consent in resuscitation trials: benefit or harm for patients and society?. Resuscitation 70 3 (2006) 360-368
41. Schulz K.F. Subverting randomization in controlled trials. JAMA 274 18 (1995) 1456-1458
42. Turner J., Nicholl J., Webber L., Cox H., Dixon S., and Yates D. A randomised controlled trial of prehospital intravenous fluid replacement therapy in serious trauma. Health Technol Assess (Winchester, England) 4 31 (2000) 1-57
43. McLean S.A., Maio R.F., Spaite D.W., and Garrison H.G. Emergency medical services outcomes research: evaluating the effectiveness of prehospital care. Prehosp Emerg Care 6 Suppl 2 (2002) S52-S56
44. Spaite D.W., Maio R., Garrison H.G., Desmond J.S., Gregor M.A., Stiell I.G., et al. Emergency Medical Services Outcomes Project (EMSOP) II: developing the foundation and conceptual models for out-of-hospital outcomes research. Ann Emerg Med 37 6 (2001) 657-663
45. Garrison H.G., Maio R.F., Spaite D.W., Desmond J.S., Gregor M.A., O'Malley P.J., et al. Emergency Medical Services Outcomes Project III (EMSOP III): the role of risk adjustment in out-of-hospital outcomes research. Ann Emerg Med 40 1 (2002) 79-88
46. Pocock S.J. Clinical trials: a practical approach (1983), John Wiley and Sons, New York
47. Assmann S.F., Pocock S.J., Enos L.E., and Kasten L.E. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355 9209 (2000) 1064-1069 [see comments]
48. Jennison C., and Turnbull B.W. Group sequential methods with applications to clinical trials (2000), Chapman & Hall, New York
49. Yusuf S., Wittes J., Probstfield J., and Tyroler H.A. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266 1 (1991) 93-98
50. Aufderheide T.P., Pirrallo R.G., Provo T.A., and Lurie K.G. Clinical evaluation of an inspiratory impedance threshold device during standard cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest. Crit Care Med 33 4 (2005) 734-740
51. Wenzel V., Krismer A.C., Arntz H.R., Sitter H., Stadlbauer K.H., and Lindner K.H. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 2 (2004) 105-113
52. Rothman K.J. Epidemiology an introduction (2002), Oxford University Press, New York [Chapter 9]
53. Wik L., Hansen T.B., Fylling F., Steen T., Vaagenes P., Auestad B.H., et al. Delaying defibrillation to give basic cardiopulmonary resuscitation to patients with out-of-hospital ventricular fibrillation: a randomized trial. JAMA 289 11 (2003) 1389-1395
54. Armitage P., and Parmar M. Some approaches to the problem of multiplicity in clinical trials. Proceedings of the XIII international biometric conference (1986)
55. Sankoh A.J., Huque M.F., and Dubey S.D. Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Statist Med 16 22 (1997) 2529-2542
56. Holm S. A sharper Bonferroni procedure for multiple tests of significance. Scand J Statist 6 (1979) 65-70
57. Hochberg Y. A sharper Bonferroni's procedure for multiple tests of significance. Biometrika 75 (1988) 800-803
58. Hommel G. A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 75 (1988) 383-386
59. Pocock S.J., Geller N.L., and Tsiatis A.A. The analysis of multiple endpoints in clinical trials. Biometrics 43 3 (1987) 487-498
60. Capizzi T., and Zhang J. Testing the hypothesis that matters for multiple primary endpoints. Drug Inform J 30 (1996) 949-956
61. Good P.L. Resampling methods: a practical guide to data analysis (1999), Springer-Verlag, New York
62. Chi G.Y.H. Multiple testings: multiple comparisons and multiple endpoints. Drug Inform J 32 (1998) 13475-13625
63. Jin K., and Chi G.Y.H. Application of bootstrap in handling multiple endpoints. Proceedings of the annual JSM meeting (1997)
64. Efron B., and Tibshirani R.J. An introduction to the bootstrap (1993), Chapman & Hall, New York
65. Armitage P., McPherson K., and Rowe B.C. Repeated significance tests on accumulating data. J R Statist Soc A 132 (1969) 235-244